Freeport-McMoRan
FCX
71.86
-0.70
-0.96%
Freeport-McMoRan
US · FCX
#213 by market cap
Listed 1970
71.86
-0.70
-0.96%
Live - 5344 symbols - heartbeat 25s ago
· 2026-10-08 08:28
Pre-market
70.35
-2.10%
After-hours
72.00
+0.19%
Overnight
71.20
-0.92%
- Market cap
- 103.19B
- P/E (TTM)i
- 35.23
- P/Bi
- 5.13
- EPSi
- 1.52
- Div yieldi
- 0.83%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on FCX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.27, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.81% YoY
Margins
- Gross margin
- 28.16%
- Operating margin
- 25.09%
- Net margin
- 8.50%
Key ratios & quality
- Enterprise valuei
- 108.85B
- Altman Z-Scorei
- 3.27
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.63B | 14.40B | 14.20B | 22.85B | 22.78B | 22.86B | 25.46B | 25.92B |
| Gross profit | 5.16B | 1.28B | 2.54B | 8.82B | 7.69B | 7.16B | 7.66B | 7.30B |
| Selling & admin expenses | 422.00M | 394.00M | 370.00M | 383.00M | 420.00M | 479.00M | 513.00M | 545.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.55B | 674.00M | 1.96B | 8.29B | 7.03B | 6.23B | 6.86B | 6.50B |
| Pretax profit | 3.89B | 306.00M | 1.80B | 7.66B | 6.72B | 6.01B | 6.91B | 6.37B |
| Tax | 991.00M | 510.00M | 944.00M | 2.30B | 2.27B | 2.27B | 2.52B | 2.22B |
| Net profit | 2.89B | -189.00M | 865.00M | 5.37B | 4.48B | 3.75B | 4.40B | 4.15B |
| Basic EPS | 2 | 0 | 0 | 3 | 2 | 1 | 1 | 2 |
| Diluted EPS | 1.78 | -0.17 | 0.41 | 2.90 | 2.39 | 1.28 | 1.30 | 1.52 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.73B | 7.58B | 6.97B | 5.63B | 6.23B | 7.03B |
| Gross profit | 1.51B | 2.63B | 2.14B | 1.02B | 1.66B | 2.19B |
| Selling & admin expenses | 154.00M | 127.00M | 131.00M | 133.00M | 162.00M | 135.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.30B | 2.43B | 1.96B | 811.00M | 1.44B | 1.99B |
| Pretax profit | 1.29B | 2.39B | 1.92B | 766.00M | 2.03B | 1.93B |
| Tax | 500.00M | 850.00M | 669.00M | 202.00M | 653.00M | 544.00M |
| Net profit | 793.00M | 1.55B | 1.25B | 565.00M | 1.39B | 1.39B |
| Basic EPS | 0 | 1 | 0 | 0 | 1 | 1 |
| Diluted EPS | 0.24 | 0.53 | 0.46 | 0.28 | 0.61 | 0.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 10.46B | 7.92B | 9.30B | 14.83B | 15.61B | 14.07B | 13.30B | 13.79B |
| Cash & ST investments | 4.22B | 2.02B | 3.66B | 8.07B | 8.15B | 4.76B | 3.92B | 3.82B |
| Inventory | 4.50B | 4.07B | 3.89B | 4.50B | 5.18B | 6.06B | 6.81B | 7.49B |
| Total assets | 42.22B | 40.81B | 42.14B | 48.02B | 51.09B | 52.51B | 54.85B | 58.17B |
| Total current liabilities | 3.33B | 3.21B | 3.42B | 5.89B | 6.35B | 5.82B | 5.50B | 6.02B |
| Short-term debt | 17.00M | 49.00M | 72.00M | 410.00M | 1.08B | 850.00M | 139.00M | 569.00M |
| Long-term debt | 11.12B | 9.82B | 9.68B | 9.08B | 9.58B | 8.66B | 8.91B | 8.91B |
| Total liabilities | 24,324,000,000.00 | 23,361,000,000.00 | 23,476,000,000.00 | 25,003,000,000.00 | 26,222,000,000.00 | 25,196,000,000.00 | 26,070,000,000.00 | 27,401,000,000.00 |
| Total equity | 17.89B | 17.45B | 18.67B | 23.02B | 24.87B | 27.31B | 28.78B | 30.77B |
| Retained earnings | -12.04B | -12.28B | -11.68B | -7.38B | -3.91B | -2.06B | -170.00M | 1.39B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 13.80B | 13.64B | 13.56B | 13.79B | 14.09B | 14.17B |
| Cash & ST investments | 4.39B | 4.49B | 4.32B | 3.82B | 3.74B | 4.08B |
| Inventory | 7.07B | 6.95B | 7.00B | 7.49B | 7.42B | 7.86B |
| Total assets | 56.02B | 56.49B | 56.83B | 58.17B | 58.84B | 59.73B |
| Total current liabilities | 5.94B | 5.53B | 5.53B | 6.02B | 5.91B | 6.86B |
| Short-term debt | 495.00M | 338.00M | 383.00M | 569.00M | 500.00M | 1.22B |
| Long-term debt | 8.91B | 8.91B | 8.92B | 8.91B | 8.91B | 8.17B |
| Total liabilities | 26,808,000,000.00 | 26,496,000,000.00 | 26,431,000,000.00 | 27,401,000,000.00 | 27,329,000,000.00 | 27,505,000,000.00 |
| Total equity | 29.21B | 30.00B | 30.40B | 30.77B | 31.51B | 32.22B |
| Retained earnings | 182.00M | 738.00M | 1.20B | 1.39B | 2.05B | 2.82B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.86B | 1.48B | 3.02B | 7.72B | 5.14B | 5.28B | 7.16B | 5.61B |
| Depreciation & amortization | 1.75B | 1.41B | 1.53B | 2.00B | 2.02B | 2.07B | 2.24B | 2.24B |
| Free cash flow | 1.89B | -1.17B | 1.06B | 5.60B | 1.67B | 455.00M | 2.35B | 1.12B |
| Dividends paid | -218.00M | -291.00M | -73.00M | -331.00M | -866.00M | -863.00M | -865.00M | -865.00M |
| Stock buybacks / issuance | 3.50B | 0 | 0 | -488.00M | -1.35B | 0 | -59.00M | -107.00M |
| Ending cash balance | 4.46B | 2.28B | 3.90B | 8.31B | 8.39B | 6.06B | 4.91B | 4.17B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.06B | 2.20B | 1.66B | 693.00M | 1.50B | 2.05B |
| Depreciation & amortization | 466.00M | 668.00M | 625.00M | 485.00M | 514.00M | 523.00M |
| Free cash flow | -114.00M | 934.00M | 608.00M | -312.00M | 522.00M | 944.00M |
| Dividends paid | -218.00M | -215.00M | -216.00M | -216.00M | -218.00M | -216.00M |
| Stock buybacks / issuance | -55.00M | -52.00M | 0 | 0 | -93.00M | -110.00M |
| Ending cash balance | 4.95B | 4.82B | 4.65B | 4.17B | 4.15B | 4.49B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 29.28 | -2.53 | 6.12 | 35.65 | 23.48 | 11.46 | 11.02 | 12.08 |
| ROA %i | 6.54 | -0.58 | 1.44 | 9.55 | 7.00 | 3.57 | 3.52 | 3.90 |
| ROIC %i | 15.75 | 1.04 | 5.23 | 21.56 | 15.27 | 8.17 | 7.76 | 8.62 |
| 5-year avg ROE %i | -21.04 | -20.20 | -0.23 | 18.88 | 18.40 | 14.85 | 17.56 | 18.74 |
| EBIT margin %i | 25.97 | 6.43 | 16.87 | 36.16 | 31.94 | 28.53 | 28.39 | 26.01 |
| FCF / sales %i | 10.16 | -- | 7.44 | 24.51 | 7.33 | 1.99 | 9.24 | 4.31 |
| Current ratioi | 3.14 | 2.47 | 2.72 | 2.52 | 2.46 | 2.42 | 2.42 | 2.29 |
| Quick ratioi | 1.66 | 0.99 | 1.48 | 1.66 | 1.57 | 1.10 | 0.92 | 0.91 |
| Debt / assetsi | 26.39 | 24.69 | 23.58 | 20.34 | 21.44 | 18.77 | 17.75 | 18.04 |
| LT debt / equityi | 113.53 | 107.82 | 96.98 | 66.95 | 63.50 | 53.93 | 54.60 | 52.51 |
| Interest coveragei | 5.12 | 1.49 | 4.01 | 13.72 | 12.99 | 12.66 | 22.65 | 18.27 |
| Revenue CAGR (3Y) %i | 8.44 | -0.97 | -4.70 | 7.04 | 16.51 | 17.20 | 3.67 | 4.39 |
| Net income CAGR (3Y) %i | -- | -- | -30.92 | 18.28 | -- | 45.58 | -24.02 | -14.02 |
| FCF CAGR (3Y) %i | -- | -- | -31.29 | 43.58 | -- | -24.47 | -25.11 | -12.57 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.20 | 10.81 | 11.44 | 12.08 | 14.70 | 15.37 |
| ROA %i | 3.21 | 3.46 | 3.69 | 3.90 | 4.76 | 5.07 |
| ROIC %i | 7.30 | 7.76 | 8.26 | 8.62 | 10.56 | 11.18 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 27.45 | 27.80 | 27.59 | 26.01 | 28.49 | 27.37 |
| FCF / sales %i | 6.42 | 6.55 | 6.25 | 4.31 | 6.63 | 6.81 |
| Current ratioi | 2.32 | 2.47 | 2.45 | 2.29 | 2.39 | 2.07 |
| Quick ratioi | 0.96 | 1.07 | 1.05 | 0.91 | 0.98 | 0.79 |
| Debt / assetsi | 16.79 | 16.38 | 16.36 | 18.04 | 17.68 | 17.34 |
| LT debt / equityi | 50.37 | 48.95 | 47.71 | 52.51 | 50.76 | 45.45 |
| Interest coveragei | 22.75 | 24.42 | 21.81 | 18.27 | 18.23 | 16.62 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- United States Rod & Refining is the largest reported line at 31.85% of revenue, across 9 reported segments.
- No single line clears half of revenue; United States Copper Mines - Other is next at 21.70%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
United States Rod & Refining31.85%
United States Copper Mines - Other21.70%
Cerro Verde21.16%
Indonesia Operations21.10%
Atlantic Copper Smelting & Refining14.65%
Morenci10.76%
South America Operations - Other4.60%
Molybdenum Mines2.90%
Quote time 2026-10-08 08:28:53 · For reference only, not investment advice and not tailored to your situation.